UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021
Go back to UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021| (NYSE: UCB) | Delayed: 36.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.14 | 52 Week High | $ | |||
| Open | $36.14 | 52 Week Low | $ | |||
| Day High | $36.14 | P/E | N/A | |||
| Day Low | $36.14 | EPS | $ | |||
| Volume | 953 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 128.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $128.64 | 52 Week High | $46.25 | |||
| Open | $128.64 | 52 Week Low | $32.74 | |||
| Day High | $128.64 | P/E | N/A | |||
| Day Low | $128.64 | EPS | $0.00 | |||
| Volume | 1,193 | |||||

